Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biological product deviation report summary posted

This article was originally published in The Gray Sheet

Executive Summary

CBER's 1FY 2002 biological product deviation report annual summary notes that the center is reviewing comments on two 2001 draft guidances on criteria for reportable biological product deviations (BPD) and that CBER expects to issue the final guidances "in the near future." In vitro diagnostic manufacturers submitted 93 BPD reports in fiscal 2002, compared with 28 in 2001. The year-over-year jump in BPD reports for the IVD sector represents the largest increase among non-blood manufacturers...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT018260

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel